Literature DB >> 19140003

Experience of the out-patient use of memotropil in the treatment of cognitive disorders in patients with chronic progressive cerebrovascular disorders.

T T Batysheva1, L V Bagir', E V Kostenko, I Yu Artemova, T V Vdovichenko, P A Ganzhula, E Yu Zhuravleva, A M Ismailov, L N Lisenker, O V Nesterova, O V Otcheskaya, L D Rotor, A A Khozova, A N Boiko.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19140003     DOI: 10.1007/s11055-009-9109-7

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


× No keyword cloud information.
  4 in total

1.  Severity of vascular dementia is related to volume of metabolically impaired tissue.

Authors:  R Mielke; K Herholz; M Grond; J Kessler; W D Heiss
Journal:  Arch Neurol       Date:  1992-09

2.  [Mild forms of multi-infarct dementia: effectiveness of cerebrolysin].

Authors:  N V Vereshchagin; E M Nekrasova; N V Lebedeva; Z A Suslina; O I Solov'ev; M A Piradov; M N Altunina
Journal:  Sov Med       Date:  1991

3.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

Review 4.  The dementias: correlation of clinical features, pathophysiology, and neuroradiology.

Authors:  R D Tien; G J Felsberg; N J Ferris; A K Osumi
Journal:  AJR Am J Roentgenol       Date:  1993-08       Impact factor: 3.959

  4 in total
  1 in total

Review 1.  Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders.

Authors:  Andrei G Malykh; M Reza Sadaie
Journal:  Drugs       Date:  2010-02-12       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.